Coronavirus Update - 31 MARCH
As we have organized this meeting in relation to the ESPID we will run Pediatric Transplant ID Workshop 2021 as scheduled in conjunction with this meeting. To stay updated on developments in relation to the Pediatric Transplant ID Workshop 2021, make sure you are signed up for our newsletter.
We at Expert Medical Events have been closely monitoring the global outbreak of COVID-19 and will continue to follow current events to ensure that this remains a safe and appropriate time to hold the meeting.
- If you are no longer able to attend, please see our cancellation policy.
- If you have reserved a networking dinner ticket and are no longer able to attend, please contact Christina Dammers at email@example.com for more information.
We are available to answer any questions or concerns that you may have about your participation at the Pediatric Transplant ID Workshop 2021. For more information, please contact firstname.lastname@example.org
While the field of pediatric organ transplantation has vastly improved in the last few decades, infectious diseases (IDs) still pose a substantial risk to children before and after transplantation.
IDs contracted after heart transplants are the second-leading cause of death in children (1). Common IDs that occur after transplantation are bacterial, fungal, and viral infections (2). These can be acquired via the healthcare setting or through donor-recipient transmission
(3). Infections that occur during the first month are mostly bacterial infections, while infections between one to six months after the transplantation are mostly viral, such as the cytomegalovirus (CMV) and the Epstein-Barr virus (EBV). After six months, infection with hepatitis B and C, CMV, EBV, or papillomavirus affect approximately 10% of patients (3). As the pediatric immune system differs from the adult immune system (1), IDs remain a significant issue for pediatric transplant patients. Specific knowledge and expertise are urgently needed in order to effectively prevent, diagnose, and treat pediatric transplant IDs (4).
New diagnoses, treatments, and preventive strategies have led to substantial improvement in the management of IDs and other complications that occur due to pediatric organ transplantation. However, the challenge of staying abreast of these considerable advances has also contributed to a knowledge gap among many clinicians regarding the optimal diagnosis and treatment of IDs in pediatric transplant patients. With an increasing number of specialists focusing on pediatric transplant IDs in a field that continues to grow, there is a need for a program dedicated to building expertise among clinicians and providing education on the latest news in the field.
Thus the Pediatric Transplant ID Workshop was created to be a unique event meant to address the knowledge gaps within the field of pediatric transplant IDs. We proudly collaborate with an extensive global network of experts from various backgrounds in the field to provide the most relevant, state-of-the-art program sure to spark engaging discussion among peers and mentors. Please join us in Rotterdam, the Netherlands for the first edition of this innovative conference to explore in-depth the most important issues facing the field of pediatric transplant IDs.
References1. Tsuda T., Dadlani G.H. and Pizzarro C. (2018) “Pediatric Heart Transplant in the United States: Current Status, Outcomes, and Ongoing Challenges.” Journal of Pediatric Cardiology and Cardiac Surgery
2. Green M. & Michaels M.G. (2012) Infections in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society
3. Allen U.D. (2013) “Minimizing infection risks after paediatric organ transplants: Advice for practitioners.” Paediatrics & Child Health
4. Danziger-Isakov L. et al. (2013) Recommended curriculum for training in pediatric transplant infectious diseases. Journal of the Pediatric Infectious